PRESIDENT'S MESSAGE

ISD: GETTING BIGGER AND BETTER
It's hard to believe that 777 days have quickly passed since I was elected the 14th ISD President in Delhi, India. How time flies! What have the seven members of the executive committee, eight standing committees, one task force and 35 board members done so far? With much inspiration and wisdom from our elders, we continuously increase our numbers globally, update them with our projects, meetings and congresses, contribute to education (International Journal of Dermatology) and award deserving members (Maria Duran fellowship, Global Education award, Community Dermatology award and Mentorship award).
The current President-appointed Nominating Committee (NC) is the last but not least. With a distinctive task, its work begins as early as two years prior to the election and ends only when the process is over. It has the colossal responsibility of tendering the slate/names of our future leaders. ISD's election is a noncontested one, which simply means that there is no need to prepare multiple candidates for a single position --making the NC's job a difficult one when multiple candidates apply for one position. Chairing this committee is Dr. Jorge Ocampo-Candiani (Mexico), with members Drs. Adebola Obunyi (Nigeria), Rekha Sheth (India), Suzanne Olbricht (US) and Luca Borradori (Switzerland).
In accordance with the bylaws of the ISD, the NC of the ISD invites applications from the general membership population for the following positions: President, Executive Vice President, SecretaryGeneral, Treasurer, 10 Vice Presidents, 25 Board of Directors and Historian/Archivist --all of whom are nominated members.
The NC will submit the slate for the vote of the membership at the XII International Congress of Dermatology (ICD) in Argentina in April 2017. The membership votes on the slate of nominees at the ICD's General Membership Meeting. With the 2017 ICD fast approaching, let's all get involved to ensure that ISD continues its long-standing tradition of electing dedicated, thoughtful leaders who will continue advancing the mission of the ISD.
Have a prosperous, successful and peaceful 2016! MABUHAY! Evangeline B. Handog, MD ISD President ISD President Dr. Evangeline Handog (behind banner in center in white dress) celebrates World Skin Health Day on November 11, 2015, on behalf of ISD and ILDS at Elsie Gaches Village in the Philippines. Dr. Handog serves as a volunteer dermatologist for Elsie Gaches Village, the only government center for mentally challenged persons --most of them abandoned or orphaned children --in the Philippines. An interview on Dr. Handog's involvement with Elsie Gaches Village was featured in the Fall 2012 issue of ISD Connection newsletter, which is posted online at www.intsocderm.org.
FROM THE SECRETARY-GENERAL
Dear friends and colleagues, It is my sincere hope that New Year 2016 brings happiness, stability, and peace to the world.
In this spirit, I truly believe that the International Society of Dermatology carries unparalleled value to the world community. As an international network of dermatologists, we thrive on improving skin care for all, sharing the latest knowledge and technology, and maintaining the grass-root network of dermatologists worldwide.
I am pleased to report to you the overwhelming success of our last year's regional meetings, judged by the robust feedback from participants and attendees.
However, once the bar is raised, we, the Executive Board, have to work even harder to maintain the level of excellence in education and ability to support our young, talented, and motivated dermatologists in the upcoming years. This is one of the central missions of ISD, and the one that is near and dear to my heart: nurture future leaders from the underserved, underfunded, and most-needed corners of the world.
With the adoption of my motto "Dermatologists Without Borders" and the thaw in U.S.-Cuban relations, a few ISD members are about to leave for the very first meeting with Cuban dermatologists in Havana right before the American Academy of Dermatology (AAD) 2016 Annual Meeting in Washington, D.C.
The planning process for this historic meeting started a year ago by our EC member and treasurer, Dr. George Reizner (US), who personally contacted the president of the Cuban Society with a proposal of this mutually rewarding exploratory visit and an establishment of a bridge between our societies.
I am enthusiastically inviting all of you, my friends, to our dashing annual ISD party on Monday night, March 7, at the AAD in Washington. You will have plenty of opportunity for networking with your colleagues, an exchange and update on the latest news, especially the much-anticipated 5th Continental Congress of Dermatology (CCD) in Dubai in April 2016. The motto of this meeting, "Skin Health is our Concern", speaks to the unique focus on dermatology, expert skin care and laser technologies. It is sure to be a top-notch educational and cultural highlight of the year! In the meantime, stay tuned and follow ISD on our Facebook page and website. 
ISD Member Fights for Leishmaniasis Patients Amidst War in Yemen
In the span of nearly three years since ISD member Dr. Mohamed Al-Kamel's (Yemen) Regional Leishmaniasis Control Center (RLCC) project was featured in the Summer 2013 ISD newsletter, a lot has changed in Yemen. The ongoing war has taken a toll on everyday life --displacing countless people and at times making basic necessities scarce.
Here, Dr. Al-Kamel, RLCC chairman and founder, shares his experience and challenges in continuing needed medical care for those suffering from leishmaniasis in Yemen.
Since you last updated us on the RLCC in Yemen in 2013, war has ravaged your region of the world. How has the war affected your efforts to help those suffering from leishmaniasis?
The ongoing war in Yemen (started in March 2015) forced us to close the head RLCC unit in Sana'a for three months (April-June 2015), restricted our ability to evoke more field campaigns, and deprived some leishmaniasis victims --specifically in the southern and eastern regions --from reaching our centers.
It is observed that the war pushed millions of big city inhabitants out to villages, where leishmaniasis is endemic. Currently, increased numbers of leishmaniasis cases --in-between who were considered urban inhabitants before the war --are seen. I noticed that wounds in injured fighters represent easy meals for leishmaniasis vectors (female sand flies)! Given the magnificent growth of dogs, rodents, and flies in the cities, I expect a future increase in leishmaniasis among the urban populations who were considered the lowest risk groups.
Despite the scarcity of resources, war and instability, my "Eradication of Leishmaniasis from Yemen Project" (ELYP) has made a difference in the leishmaniasis situation in Yemen. We have addressed the magnitude of the disorder and eradicated it from some areas in central Yemen. We have dealt with and improved its alarming prevalence among children and women, being the neglected and highest risk groups. Issues associated with poor access to proper drugs were solved. Our cause has attracted local and global attention to these problematic issues.
In October 2014, ISD executive committee members successfully lobbied Stiefel/GSK pharmaceutical to provide a generous supply of anti-leishmaniasis medication (Pentostam® injections) to this project over three years. While ISD requested 100 vials annually for three years, Stiefel/GSK decided to donate three times the requested amount --donating 300 vials annually. This donation has enabled leishmaniasis patients to freely receive medicine they otherwise would not have been able to afford, reducing their mortality and morbidity, and minimizing the extensive impact the socio-aesthetic stigma has on their lives.
Thanks to ELYP, ISD, AAD and ILDS, awareness of the disease that was near zero has been significantly increased in the community. Now, most physicians in the rural and urban health units are aware and interested in the disease and have at least the essential knowledge on how to diagnose, manage and refer leishmaniasis patients. As a result, the research capabilities of leishmaniasis in Yemen have improved.
How many leishmaniasis patients is your organization treating each month? What treatments are you currently using, and has the war affected your medical supplies in any way?
RLCC welcomes an average of 67-100 leishmaniasis patients monthly, most of whom are poor rural women and children who receive free examination, medicine and educational newsletter. Currently, only Pentostam ® injections are available freely to our patients.
Unfortunately, the current war has delayed RLCC receiving the second quantity of GSK/Stiefel medicine donation on time.
Have you noticed an increase in any other dermatological conditions over the past three years?
As to visceral leishmaniasis, yes. There was an alarming increase, as per our records, in the incidence --from 3% in 2013 to 5.14% by the end of 2015. Noticeable also was the significant increase in skin malignancies and auto-immune skin disorders over the past three years.
How can ISD members help or contribute to your program? What are your greatest needs?
The next phase of partnership with project ELYP should include, in addition to additional medicine donation, the possibility of medical staff training, molecular diagnosis, clinical research sponsorships, disfigured women rehabilitation program, and improvement of the access to our services for populations living in remote areas.
Our patients are in imperative need to other alternative substitutes, such as meglumine antimonite (Glucantime ® ), amphotericin B, and paromomycin for those who cannot tolerate sodium stibogluconate antimonials.
ELYP's surveillance, educational and management remote field campaigns are in need for vehicles and camping capabilities.
RLCC is in need of well-equipped clinics and lecture rooms at our branch units. It needs a sponsor to cover the basic operational costs, provide the laboratory with ELISA diagnostic kits, and provide patients with some protective means (bed nets, repellent creams, etc.).
Ultimately, public investment in our educational, treatment and control programs would decrease the leishmaniasis' local and global disease burden.
Dr. Al-Kamel (standing, wearing sunglasses) leading an ELYP awareness-raising and treatment campaign at a marginalized camp in Al Dhale', a governorate at Central Yemen.
Dr. Al-Kamel seeing leishmaniasis patients in a primary health unit at a district where all inhabitants had leishmaniasis in Ibb governorate at central Yemen --the most densely populated governorate in Yemen outside of Sana'a city.
Before and after photos of disseminated cutaneous leishmaniasis (DCL) in a Yemeni female child (all of her family members had the same condition), managed and granted free medicine at the RLCC's clinic in Sana'a, the capital city.
Leishmaniasis patients seen and given free medicine by ELYP volunteers at the RLCC's Al Baydaa Unit, Radaa district, Yemen. This is a program of social assistance, focusing on the care of patients with skin disease in underserved communities and providing needed medications free of charge. Another main component is promoting the teaching of basic dermatology to health care professionals.
Website
How was the idea for this Community Dermatology project conceived?
The project began as a response to the growing needs in the communities to identify and appropriately treat patients with various dermatological diseases. We identified that specific diseases were prevalent, especially subcutaneous mycoses. Through the support of institutions such as the Ministry of Health and local government programs, the visits were extended. We have worked with the International Foundation for Dermatology (IFD), the International League of Dermatological Societies (ILDS) and the American Academy of Dermatology (AAD).
Who is part of this program?
We are a private non-profit organization based in Mexico. In order to visit the various communities, we have the support of national and international dermatologists, dermatology residents, medical students and others who selflessly share our interest and appreciation for this social work --promoting awareness and empathy for the needs of people in underserved communities.
Where do volunteers provide assistance?
Volunteers of the program have visited many times the seven regions of the State of Guerrero for over 23 years, providing more than 18,000 consultations in approximately 400 communities visited. Recently, the volunteer efforts have been extended to other regions of the Mexican Republic. We also have supported and encouraged that this program be replicated in other countries such as Argentina and Africa.
What is the greatest impact of the program to these communities?
One of the main objectives is to provide specialized care to the community, improve the quality of life of patients with disabling diseases --such as mycetoma, tuberculosis and sporotrichosis --identify genetic diseases, and help with their treatment. In addition, the teaching given during the courses can train health care professionals, who in turn will be able to identify various skin diseases for reference and timely patient care.
How often do volunteers visit these communities?
The visits average three to six per year, which will vary depending on the identified communities with the greatest needs.
Who can participate and how can they contact this program?
We invite all health care professionals with an interest in dermatology or social assistance in health to participate in the conference on education in basic dermatology and dermatology community workshops. You can contact us through our website www.dermatologíacomunitaria.org.mx or email us at contacto@ dermatologiacomunitaria.org.mx.
What satisfaction do you get personally from this program?
It is a way to give back in some way. The wonderful experience to be a doctor --helping others in less favorable conditions --knowing that diseases treated in time may be curable and thus prevent consequences that sometimes are irreversible. We give patients the treatment they need and we have the ability, through our specialty, to help. Dermatology is a branch of medicine in which many diseases are visible, tangible and treatable without sophisticated studies. Dermatologists must commit to improve the health and quality of life of our patients, so we invite you to join us and help make a difference. I often visit hospital departments overseas and see bullous disease patients, and we learn from each other that way. I see the ISD leading the way in giving more platforms for regional dermatology practices to be seen. ISD could be a stakeholder in the development of traditional medicines into extracts with scientifically sound and safe indications in dermatology, and we could set up a committee to work on this area.
How do you balance your personal life with your professional life?
I have always had a lot of energy, and my mother, aunt and grandmother were good role models for balancing careers, volunteering and raising children. Our two sons, now 21 and 19 and away at college, and our 17-year-old daughter, come on holidays with us and have the wanderlust genes as well. We all focus on work during the week and have family time for watching their sports, seeing friends and family on weekends.
Besides dermatology, what else are you passionate about?
I enjoy historical places and reading historical fiction. I love exploring new places and meeting people from different races, religions and backgrounds. I run regularly and love dancing. And I'm especially fond of foreign films. 
Dr. Gibson, you served for 13 years as editor of the
What is your fondest memory of serving as the IJD editor?
When we were at one of our earlier Editorial Board meetings in 2003 and it was clear we were making definite headway with the Journal, and to receive positive feedback from the Executive Committee of the ISD and from so many members of the Society… I remember that as a huge relief and an uplifting experience! I have had many, many fond memories related to the Journal and feel very blessed to have had the opportunity to serve in that role.
What three words best describe you?
Kind, thoughtful and disciplined would be three that I aspire to, but hopefully others would agree to describe me with those words as well.
Dr. Dedee Murrell
Dr. Lawrence Gibson Behind the Scenes: Getting to Know your ISD Board Members
Despite busy professional and personal lives, members of the ISD Board of Directors spend a significant amount of time working to improve the quality of all the benefits the Society offers its members. Whether overseeing the editorial content of the ISD newsletter or helping plan one of the ISD's many educational programs, ISD Board Members play a vital role in nearly all aspects of ISD. A term is considered from the start of one ICD to the next ICD (generally four years). The next ICD will take place in April 2017.
Here, meet two ISD Board Members who have been heavily involved in ISD -
Only Regular and Individual Sponsoring Members in good standing for at least three years may be nominated for the Board of Directors (including Officers). Nominees will be selected from the applications based on leadership skills, ethical conduct, commitment to the specialty of dermatology and level of activity within the Society.
Officers
President (1 term Dr. Venida-Tablizo's rotations were focused on infectious dermatology, as leprosy is her advocacy. She also had the chance to rotate in the departments of bacteriology, microbiology, allergology and trichology where she was exposed to many standard procedures that are not routinely done in her hospital in the Philippines due to the high costs. The daily conferences she participated in were invaluable, as she realized the importance of reviewing actual cases seen during the day. Dr. Sabido spent three months, from August to October 2015, in the Division of Dermatology of the King Chulalongkorn Memorial Hospital in Bangkok, Thailand, where she was further exposed to psoriasis cases, followed by eczemas, vitiligo, mycosis fungoides, and pruritus. Ascertaining various management techniques of these dermatoses using photodermatology definitely enhanced her knowledge and skill. She described her learning experience there as some of the most fulfilling and academically enriching months of her medical career.
According to Dr. Pravit, "I don't think that you should just treat patients; I think you should create an experience [for them]. They should go out of your clinic happy." These words left a lasting impression on her. Dr. Sabido believes that he applies this "creating an experience" not just on how he treats his patients, but also on how he teaches his students and inspires other people to learn from him.
At the end of her fellowship, Dr. Sabido was tasked to give a talk on phototherapy, which led her to a better understanding and appreciation of this field. She also took Dr. Pravit's advice to heart, inspiring her to be a more compassionate dermatologist and in doing so "creating an experience" for her patients. 
